Evidence map›Paper›PMID 19615967›Full record

ArticleAnalytical biochemistry2009

Detecting low-abundance vasoactive peptides in plasma: progress toward absolute quantitation using nano liquid chromatography-mass spectrometry.

Mark Lortie, Steven Bark, Roland Blantz, Vivian Hook

Open access · greenAbstract read
In one paragraph

Article in Analytical biochemistry, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.2field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Biochemical evaluation of the renin-angiotensin system: the good, bad, and absolute?American journal of physiology. Heart and circulatory physiology · 2016
    Review
  7. Review
  8. Article
  9. Article
  10. Mass spectrometry for the molecular imaging of angiotensin metabolism in kidney.American journal of physiology. Endocrinology and metabolism · 2012
    Article
  11. Review
  12. Article
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Mark LortieDivision of Nephrology and Hypertension, VA San Diego Healthcare System, Biomarker and Diagnotics Discovery Center, Department of Pathology, UCSD School of Medicine, San Diego, CA 92093-0612, USA. mlortie@ucsd.edu
Steven Bark
Roland Blantz
Vivian Hook
University of California, San Diego · USVeterans Medical Research Foundation of San Diego · US

Funding

Trafficking of catecholamine storage vesicle proteinsP01HL058120 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI HOOK, VIVIAN Y. H · 1999 to 2009
$18.5M
UAB-UCSD O'Brien Core Center for Acute Kidney Injury ResearchP30DK079337 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI CURTIS, LISA M · 2008 to 2022
$18.3M
AUTOREGULATION OF GLOMERULAR FILTRATION RATER01DK028602 · NIDDK · VETERANS MEDICAL RESEARCH FDN/SAN DIEGO · PI BLANTZ, ROLAND C · 1986 to 2011
$3.9M
Serpin Protease Inhibitors &Opioid NeuropeptidesR01NS024553 · NINDS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI HOOK, VIVIAN Y. H. · 1987 to 2006
$2.5M
BIOSYNTHESIS OF ENKEPHALIN OPIOID PEPTIDESR01DA004271 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI HOOK, VIVIAN Y. H · 1987 to 2009
$2.5M
POMC Processing Beta-Endorphin-Related Opioid PeptidesR01MH077305 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI HOOK, VIVIAN Y. H · 2006 to 2010
$1.6M
Cathepsin L in the Biosynthesis of Enkephalins and beta-Endorphin Opioid PeptidesK01DA023065 · NIDA · UNIVERSITY OF HOUSTON · PI BARK, STEVEN · 2008 to 2012
$735k
NHLBI NIH HHS P01 HL058120NHLBI NIH HHS P01 HL58120NIDA NIH HHS 1K01DA023065-01A1NIDA NIH HHS K01 DA023065NIDA NIH HHS R01 DA004271NIDDK NIH HHS 5-R01 DK28602NIDDK NIH HHS P30 DK079337NIDDK NIH HHS R01 DK028602NIMH NIH HHS R01 MH077305NINDS NIH HHS R01 NS024553
6 · The paper itself

Abstract

Profiling changes in the concentration of functionally related peptide hormones is critical to understanding the etiology of many diseases and therapies. We present novel data using nano liquid chromatography-mass spectrometry (LC-MS) to simultaneously measure a select group of vasoactive peptides (angiotensin, bradykinin, and related hormones) in 50-microl plasma samples, enabling repeated sampling in rodent models. By chromatographically resolving target peptides and using multiple reaction monitoring to enhance MS sensitivity, linear responses down to 10(-17) mol were achieved. Purification of plasma peptides by either methanol precipitation or off-line high-performance liquid chromatography (HPLC) fractionation enabled the detection of endogenous peptides and revealed approaches for enhancing recovery. As proof of principle, seven vasoactive peptides were profiled before, during, and after acute angiotensin-converting enzyme (ACE) inhibition in an anesthetized rat. Of note was an apparent 10-fold increase in vasodilatory bradykinin that reversed after drug infusion but relatively minor changes in angiotensin II levels. Targeted MS analysis used to profile functionally related peptides or other analytes will greatly enhance our ability to define the sequence of events regulating complex and dynamic physiological processes.

Indexed as

AnimalsChromatography, LiquidMaleMass SpectrometryNanotechnologyPeptidesRatsRats, WistarReference StandardsReproducibility of ResultsTime FactorsPeptides

Identifiers

PMID19615967
PMCPMC2745394
OpenAlexW2036313999

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.